Wegovy gets EU regulator backing on lowering heart risks in obese people
The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic.
HQ Team March 4, 2024: Bayer AG, a German multinational pharmaceutical and biotechnology company, has bought the marketing rights in Europe for a.
HQ Team March 1, 2024: Pfizer Inc., a US pharmaceutical and biotechnology corporation, announced its single dose of respiratory syncytial virus (RSV) vaccine.
HQ Team October 21, 2023: The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.
HQ Team September 2, 2023: A panel of the European Union’s health regulator, the European Medicines Agency, has warned against the use of.